Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases
Open Access
- 1 April 1999
- Vol. 85 (7), 1537-1546
- https://doi.org/10.1002/(sici)1097-0142(19990401)85:7<1537::aid-cncr15>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerThe Lancet, 1997
- Parametrial involvement, regardless of nodal status: A poor prognostic factor for cervical cancerObstetrics & Gynecology, 1996
- The uses and limitations of DNA flow cytometry in stage IB or II cervical carcinomaCancer, 1993
- A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncology Group studyGynecologic Oncology, 1989
- Adjuvant chemotherapy after radical hysterectomy for cervical carcinomaGynecologic Oncology, 1989
- Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control studyGynecologic Oncology, 1989
- Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancerCancer, 1989
- Vascular invasion in stage I carcinoma of the cervixCancer, 1984
- Results of radiation therapy given after radical hysterectomyCancer, 1982
- Prognosis of uterine cervical cancer with extensive lymph node metastasesAmerican Journal of Obstetrics and Gynecology, 1972